Prostaglandin E2 production in ovarian cancer cell lines is regulated by cyclooxygenase-1, not cyclooxygenase-2

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 73, Issue 2, 2005, Pages 103-111

  Kino, Yuko ^a   Kojima, Fumiaki ^a   Kiguchi, Kazushige ^a   Igarashi, Rie ^a   Ishizuka, Bunpei ^a   Kawai, Shinichi ^a,b,c  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; ROFECOXIB; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOSOL; ENZYME REGULATION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; BIOSYNTHESIS; CELL PROLIFERATION; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENETICS; METABOLISM; OVARY TUMOR; TUMOR CELL LINE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE, TUMOR; CELL PROLIFERATION; DINOPROSTONE; FEMALE; HUMANS; OVARIAN NEOPLASMS; RNA, MESSENGER;

EID: 22444447964     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2005.04.014     Document Type: Article

References (41)

1. M. Daly, and G.I. Obrams Epidemiology and risk assessment for ovarian cancer Semin. Oncol. 25 1998 255 264
2. S.D. Pack, O.M. Alper, and K. Stromberg Simultaneous suppression of epidermal growth factor receptor and c-erbB-2 reverses aneuploidy and malignant phenotype of a human ovarian carcinoma cell line Cancer Res. 64 2004 789 794
3. J. Vane Towards a better aspirin Nature 367 1994 215 216
4. S. Kawai, S. Nishida, and M. Kato Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells Eur. J. Pharmacol. 347 1998 87 94
5. A. Ristimaki, N. Honkanen, H. Jankala, P. Sipponen, and M. Harkonen Expression of cyclooxygenase-2 in human gastric carcinoma Cancer Res. 57 1997 1276 1280
6. R.R. Tjandrawinata, R. Dahiya, and M. Hughes-Fulford Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells Br. J. Cancer 75 1997 1111 1118
7. A. Kirschenbaum, A.P. Klausner, and R. Lee Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate Urology 56 2000 671 676
8. R.A. Soslow, A.J. Dannenberg, and D. Rush COX-2 is expressed in human pulmonary, colonic, and mammary tumors Cancer 15 2000 2637 2645
9. C.N. Landen Jr, S.P. Mathur, M.S. Richardson, and W.T. Creasman Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies Am. J. Obstet. Gynecol. 188 2003 1174 1176
10. C. Denkert, M. Kobel, and S. Pest Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma Am. J. Pathol. 160 2002 893 903
11. I. Khalifeh, A.R. Munkarah, and F. Lonardo Expression of Cox-2, CD34, Bcl-2, and p53 and survival in patients with primary peritoneal serous carcinoma and primary ovarian serous carcinoma Int. J. Gynecol. Pathol. 23 2004 162 169
12. S.S. Seo, Y.S. Song, and D.H. Kang Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer Gynecol. Oncol. 92 2004 927 935
13. M.R. Raspollini, G. Amunni, and A. Villanucci Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome Gynecol. Oncol. 92 2004 806 812
14. R. Ali-Fehmi, M. Che, and I. Khalifeh The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma Cancer 98 2003 1423 1429
15. H.T. Sorensen, S. Friis, and B. Norgard Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study Br. J. Cancer 88 2003 1687 1692
16. A. Tavani, S. Gallus, C. La Vecchia, E. Conti, M. Montella, and S. Franceschi Aspirin and ovarian cancer: an Italian case-control study Ann. Oncol 11 2000 1171 1173
17. R. Lynn, R.P. Julie, and R. Sowmya Rao A case-control study of analgesic use and ovarian cancer Cancer Epidemiol. 9 2000 933 937
18. C. Rodriguez-Burford, M.N. Barnes, and D.K. Oelschlager Effects of nonsteroidal anti-inflammatory agents (NSAIDs) on ovarian carcinoma cell lines: preclinical evaluation of NSAIDs as chemopreventive agents Clin. Cancer. Res. 8 2002 202 209
19. M. Murakami, Y. Nakatani, T. Tanioka, and I. Kudo Prostaglandin E synthase Prostaglandins Other Lipid Mediat. 68-69 2002 383 399
20. T. Tanioka, Y. Nakatani, N. Semmyo, M. Murakami, and I. Kudo Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis J. Biol. Chem. 275 2000 32775 32782
21. P.J. Jakobsson, S. Thoren, R. Morgenstern, and B. Samuelsson Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducibleenzyme, constituting a potential novel drug target Proc. Natl. Acad. Sci. USA 96 1999 7220 7225
22. N. Tanikawa, Y. Ohmiya, and H. Ohkubo Identification and characterization of a novel type of membrane-associated prostaglandin E synthase Biochem. Biophys. Res. Commun. 291 2002 884 889
23. D. Kamei, M. Murakami, Y. Nakatani, Y. Ishikawa, T. Ishii, and I. Kudo Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis J. Biol. Chem. 278 2003 19396 19405
24. B.P. van Rees, A. Sivula, and S. Thoren Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines Int. J. Cancer 107 2003 551 556
25. F. Kojima, H. Naraba, Y. Sasaki, R. Okamoto, T. Koshino, and S. Kawai Coexpression of microsomal prostaglandin E synthase with cyclooxygenase-2 in human rheumatoid synovial cells J. Rheumatol. 29 2002 1836 1842
26. F. Kojima, H. Naraba, S. Miyamato, M. Beppu, H. Aoki, and S. Kawai Membrane-associated prostaglamdin E synthase-1 is up regulated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis Arthritis Res. Ther. 6 2004 R355 R365
27. M. Kato, S. Nishida, H. Kitasato, N. Sakata, and S. Kawai Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes J. Pharm. Pharmacol. 53 2001 1679 1685
28. I. Ishiwata, C. Ishiwata, M. Soma, and H. Ishikawa Establishment and characterization of two human ovarian endometrioid carcinoma cell lines (with or without squamous cell component) Gynecol. Oncol. 25 1986 95 107
29. I. Ishiwata, C. Ishiwata, N. Kobayashi, and H. Ishikawa Characterization of newly established cell line HUOA from a human ovarian serous cystadenocarcinoma Nippon Sanka Fujinka Gakkai Zasshi 39 1987 831 836
30. S. Nozawa, K. Tsukazaki, M. Sakayori, C.H. Jeng, and R. Iizuka Establishment of a human ovarian clear cell carcinoma cell line (RMG-I) and its single cell cloning - with special reference to the stem cell of the tumor Hum. Cell 1 1988 426 435
31. I. Gorai, T. Nakazawa, E. Miyagi, F. Hirahara, Y. Nagashima, and H. Minaguchi Establishment and characterization of two human ovarian clear cell adenocarcinoma lines from metastatic lesions with different properties Gynecol. Oncol. 57 1995 33 46
32. F. Kojima, H. Naraba, Y. Sasaki, M. Beppu, H. Aoki, and S. Kawai Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts Arthritis Rheum. 48 2003 2819 2828
33. R.A. Gupta, L.V. Tejada, and B.J. Tong Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer Cancer Res. 63 2003 906 911
34. C.J. Smith, Y. Zhang, and C.M. Koboldt Pharmacological analysis of cyclooxygenase-1 in inflammation Proc. Natl. Acad. Sci. USA 95 1998 13313 13318
35. H. Kitasato, M. Noda, and T. Akahoshi Activated Ras modifies the proliferative response of rheumatoid synovial cells to TNF-alpha and TGF-alpha Inflamm. Res. 50 2001 592 597
36. S. Li, K. Miner, R. Fannin, J. Carl Barrett, and B.J. Davis Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium Gynecol. Oncol. 92 2004 622 627
37. R. Yamazaki, N. Kusunoki, T. Matsuzaki, S. Hashimoto, and S. Kawai Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells FEBS Lett. 531 2002 278 284
38. A.R. Munkarah, R. Morris, and P. Baumann Effects of prostaglandin E (2) on proliferation and apoptosis of epithelial ovarian cancer cells J. Soc. Gynecol. Invest. 9 2002 168 173
39. H. Sheng, J. Shao, M.K. Washington, and R.N. DuBois Prostaglandin E2 increases growth and motility of colorectal carcinoma cells J. Biol. Chem. 276 2001 18075 18081
40. F.G. Buchanan, D. Wang, F. Bargiacchi, and R.N. DuBois Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor J. Biol. Chem. 278 2003 35451 35457
41. R. Pai, I.L. Szabo, B.A. Soreghan, S. Atay, H. Kawanaka, and A.S. Tarnawski PGE(2) stimulates VEGF expression in endothelial cells via ERK2/JNK1 signaling pathways Biochem. Biophys. Res. Commun. 286 2001 923 928